Back to Cardiology
Cardiologyv2019Evidence-Based

VIRSTA Score for Infective Endocarditis Risk Assessment

The VIRSTA Score is a clinical decision tool used to risk-stratify suspected infective endocarditis cases before obtaining echocardiography. This score helps identify patients at very low risk for infective endocarditis who may not require immediate echocardiographic evaluation, thereby reducing unnecessary testing and healthcare costs while maintaining diagnostic safety.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
virsta score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The VIRSTA Score for Infective Endocarditis Risk Assessment is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of positive criteria: Valve disease/prosthetic valve (5 points) + Injection drug use (5 points) + Vascular phenomena (4 points) + Immunologic phenomena (3 points) + Systemic emboli (3 points) + Temperature >38°C (2 points) + Age >60 years (2 points) + WBC >11,000/μL (1 point) + Central venous catheter (1 point) + Staphylococcus aureus bacteremia (1 point)

Clinical Pearls & Practice Notes

  • Originally developed and validated in patients with Staphylococcus aureus bacteremia
  • Score ≤1 has negative predictive value >99% for ruling out infective endocarditis
  • Should be used in conjunction with clinical judgment and not as sole determinant
  • Particularly useful in emergency department and inpatient settings for triaging patients
  • May help reduce unnecessary echocardiographic studies while maintaining diagnostic safety
  • Validation studies have shown good discrimination ability (AUC 0.87-0.89)
  • Best performance when applied to patients with confirmed bacteremia and clinical suspicion of endocarditis

Evidence & Literature Citations

  1. Sunnerhagen T, Törnell A, Vikbrant M, et al. VIRSTA score: prediction of infective endocarditis and mortality in Staphylococcus aureus bacteremia; a cohort study. Clin Microbiol Infect. 2019;25(4):480-486. doi: 10.1016/j.cmi.2018.06.021
  2. Palraj BR, Baddour LM, Hess EP, et al. Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the setting of Staphylococcus aureus bacteremia. Clin Infect Dis. 2015;61(1):18-28. doi: 10.1093/cid/civ235
  3. Bouza E, Kestler M, Beca T, et al. The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis. 2015;60(4):528-535. doi: 10.1093/cid/ciu872

Score Interpretation Ranges

Very Low Risk0 – 1 pts

Very low probability of infective endocarditis

Higher Risk2 – 50 pts

Increased probability of infective endocarditis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.